JP2018530591A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2018530591A5 JP2018530591A5 JP2018519425A JP2018519425A JP2018530591A5 JP 2018530591 A5 JP2018530591 A5 JP 2018530591A5 JP 2018519425 A JP2018519425 A JP 2018519425A JP 2018519425 A JP2018519425 A JP 2018519425A JP 2018530591 A5 JP2018530591 A5 JP 2018530591A5
- Authority
- JP
- Japan
- Prior art keywords
- carbonyl
- dimethoxyphenyl
- pyridine
- diol
- butyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 125000000217 alkyl group Chemical group 0.000 claims 52
- 125000000623 heterocyclic group Chemical group 0.000 claims 38
- 229910052801 chlorine Inorganic materials 0.000 claims 28
- 229910052739 hydrogen Inorganic materials 0.000 claims 28
- 229910052731 fluorine Inorganic materials 0.000 claims 26
- 229910052799 carbon Inorganic materials 0.000 claims 24
- 229910052794 bromium Inorganic materials 0.000 claims 19
- 229910052757 nitrogen Inorganic materials 0.000 claims 14
- 125000004452 carbocyclyl group Chemical group 0.000 claims 13
- 150000003839 salts Chemical class 0.000 claims 13
- 125000004433 nitrogen atom Chemical group N* 0.000 claims 12
- 150000001875 compounds Chemical class 0.000 claims 11
- 125000005913 (C3-C6) cycloalkyl group Chemical group 0.000 claims 10
- -1 CN Inorganic materials 0.000 claims 10
- 229910004013 NO 2 Inorganic materials 0.000 claims 10
- 125000003118 aryl group Chemical group 0.000 claims 8
- 229910052736 halogen Inorganic materials 0.000 claims 8
- 229910052760 oxygen Inorganic materials 0.000 claims 8
- JXXWGJDDGHLALL-UHFFFAOYSA-N 6-butyl-3-[4-(5-chloropyridin-2-yl)piperazine-1-carbonyl]-5-(2,6-dimethoxyphenyl)-4-hydroxy-1H-pyridin-2-one Chemical compound C(CCC)C1=C(C(=C(C(=N1)O)C(=O)N1CCN(CC1)C1=NC=C(C=C1)Cl)O)C1=C(C=CC=C1OC)OC JXXWGJDDGHLALL-UHFFFAOYSA-N 0.000 claims 7
- 125000000882 C2-C6 alkenyl group Chemical group 0.000 claims 7
- 125000003601 C2-C6 alkynyl group Chemical group 0.000 claims 7
- 125000001072 heteroaryl group Chemical group 0.000 claims 7
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 7
- 125000003342 alkenyl group Chemical group 0.000 claims 6
- KLIDCXVFHGNTTM-UHFFFAOYSA-N 2,6-dimethoxyphenol Chemical group COC1=CC=CC(OC)=C1O KLIDCXVFHGNTTM-UHFFFAOYSA-N 0.000 claims 5
- 229910052717 sulfur Inorganic materials 0.000 claims 5
- JWHIEVXUXFAQDJ-UHFFFAOYSA-N 3-[3-(2,4-difluorophenyl)pyrrolidine-1-carbonyl]-5-(2,6-dimethoxyphenyl)-6-(ethoxymethyl)-4-hydroxy-1H-pyridin-2-one Chemical compound CCOCC1=C(C(O)=C(C(=O)N2CCC(C2)C2=C(F)C=C(F)C=C2)C(=O)N1)C1=C(OC)C=CC=C1OC JWHIEVXUXFAQDJ-UHFFFAOYSA-N 0.000 claims 4
- TYNFGDMXKBRIMD-UHFFFAOYSA-N 3-[3-(2,6-difluorophenyl)pyrrolidine-1-carbonyl]-5-(2,6-dimethoxyphenyl)-6-(ethoxymethyl)-4-hydroxy-1H-pyridin-2-one Chemical compound CCOCC1=C(C(O)=C(C(=O)N2CCC(C2)C2=C(F)C=CC=C2F)C(=O)N1)C1=C(OC)C=CC=C1OC TYNFGDMXKBRIMD-UHFFFAOYSA-N 0.000 claims 4
- ISWHIVGTKAPCBD-UHFFFAOYSA-N 3-[3-(3,5-difluoropyridin-2-yl)pyrrolidine-1-carbonyl]-4-hydroxy-5-(3-methoxyphenyl)-6-(2-methyl-1,3-thiazol-4-yl)-1H-pyridin-2-one Chemical compound COc1cccc(c1)-c1c(O)c(C(=O)N2CCC(C2)c2ncc(F)cc2F)c(=O)[nH]c1-c1csc(C)n1 ISWHIVGTKAPCBD-UHFFFAOYSA-N 0.000 claims 4
- LSQPBZVEEYPZNT-UHFFFAOYSA-N 3-[3-(5-chloropyridin-2-yl)pyrrolidine-1-carbonyl]-5-(2,6-dimethoxyphenyl)-6-(ethoxymethyl)-4-hydroxy-1H-pyridin-2-one Chemical compound ClC=1C=CC(=NC=1)C1CN(CC1)C(=O)C=1C(=NC(=C(C=1O)C1=C(C=CC=C1OC)OC)COCC)O LSQPBZVEEYPZNT-UHFFFAOYSA-N 0.000 claims 4
- MJRQWNRBGLQROP-UHFFFAOYSA-N 5-(2,6-dimethoxyphenyl)-6-(ethoxymethyl)-3-[3-(2-fluorophenyl)pyrrolidine-1-carbonyl]-4-hydroxy-1H-pyridin-2-one Chemical compound COC1=C(C(=CC=C1)OC)C=1C(=C(C(=NC=1COCC)O)C(=O)N1CC(CC1)C1=C(C=CC=C1)F)O MJRQWNRBGLQROP-UHFFFAOYSA-N 0.000 claims 4
- STPCTGAXOIRZLX-UHFFFAOYSA-N 5-(2,6-dimethoxyphenyl)-6-(ethylaminomethyl)-3-[3-(2-fluorophenyl)pyrrolidine-1-carbonyl]-4-hydroxy-1H-pyridin-2-one Chemical compound COC1=C(C(=CC=C1)OC)C=1C(=C(C(=NC=1CNCC)O)C(=O)N1CC(CC1)C1=C(C=CC=C1)F)O STPCTGAXOIRZLX-UHFFFAOYSA-N 0.000 claims 4
- PAHBCVGKVFBQCH-UHFFFAOYSA-N 6-butyl-3-[3-(2-chlorophenyl)pyrrolidine-1-carbonyl]-5-(2,6-dimethoxyphenyl)-4-hydroxy-1H-pyridin-2-one Chemical compound C(CCC)C1=C(C(=C(C(=N1)O)C(=O)N1CC(CC1)C1=C(C=CC=C1)Cl)O)C1=C(C=CC=C1OC)OC PAHBCVGKVFBQCH-UHFFFAOYSA-N 0.000 claims 4
- SWMRKJKGMIVBQC-UHFFFAOYSA-N 6-butyl-3-[3-(3,5-difluoropyridin-2-yl)pyrrolidine-1-carbonyl]-4-hydroxy-5-(3-methoxyphenyl)-1H-pyridin-2-one Chemical compound C(CCC)C1=C(C(=C(C(=N1)O)C(=O)N1CC(CC1)C1=NC=C(C=C1F)F)O)C1=CC(=CC=C1)OC SWMRKJKGMIVBQC-UHFFFAOYSA-N 0.000 claims 4
- KEKVIUIKJARJEV-UHFFFAOYSA-N 6-butyl-3-[3-(3,5-difluoropyridin-2-yl)pyrrolidine-1-carbonyl]-4-hydroxy-5-[3-(hydroxymethyl)phenyl]-1H-pyridin-2-one Chemical compound C(CCC)C1=C(C(=C(C(=N1)O)C(=O)N1CC(CC1)C1=NC=C(C=C1F)F)O)C1=CC(=CC=C1)CO KEKVIUIKJARJEV-UHFFFAOYSA-N 0.000 claims 4
- KNNQFRTUAOSUPW-UHFFFAOYSA-N 6-butyl-3-[3-(3,5-difluoropyridin-2-yl)pyrrolidine-1-carbonyl]-5-(2,6-dimethoxyphenyl)-4-hydroxy-1H-pyridin-2-one Chemical compound C(CCC)C1=C(C(=C(C(=N1)O)C(=O)N1CC(CC1)C1=NC=C(C=C1F)F)O)C1=C(C=CC=C1OC)OC KNNQFRTUAOSUPW-UHFFFAOYSA-N 0.000 claims 4
- BJRABZGGXKCRFF-UHFFFAOYSA-N 6-butyl-3-[3-(3-chlorophenyl)pyrrolidine-1-carbonyl]-5-(2,6-dimethoxyphenyl)-4-hydroxy-1H-pyridin-2-one Chemical compound C(CCC)C1=C(C(=C(C(=N1)O)C(=O)N1CC(CC1)C1=CC(=CC=C1)Cl)O)C1=C(C=CC=C1OC)OC BJRABZGGXKCRFF-UHFFFAOYSA-N 0.000 claims 4
- PQBPXJCTSKAMJZ-UHFFFAOYSA-N 6-butyl-3-[3-(5-chloro-3-fluoropyridin-2-yl)pyrrolidine-1-carbonyl]-5-(2,6-dimethoxyphenyl)-4-hydroxy-1H-pyridin-2-one Chemical compound CCCCC1=C(C(O)=C(C(=O)N2CCC(C2)C2=NC=C(Cl)C=C2F)C(=O)N1)C1=C(OC)C=CC=C1OC PQBPXJCTSKAMJZ-UHFFFAOYSA-N 0.000 claims 4
- QLRHTCHILRFJSZ-UHFFFAOYSA-N 6-butyl-3-[3-(5-chloropyridin-2-yl)pyrrolidine-1-carbonyl]-5-(2,6-dimethoxyphenyl)-4-hydroxy-1H-pyridin-2-one Chemical compound C(CCC)C1=C(C(=C(C(=N1)O)C(=O)N1CC(CC1)C1=NC=C(C=C1)Cl)O)C1=C(C=CC=C1OC)OC QLRHTCHILRFJSZ-UHFFFAOYSA-N 0.000 claims 4
- UOHRPIGTAUTOKW-UHFFFAOYSA-N 6-butyl-5-(2,6-dimethoxyphenyl)-3-[3-(3-fluoropyridin-2-yl)pyrrolidine-1-carbonyl]-4-hydroxy-1H-pyridin-2-one Chemical compound C(CCC)C1=C(C(=C(C(=N1)O)C(=O)N1CC(CC1)C1=NC=CC=C1F)O)C1=C(C=CC=C1OC)OC UOHRPIGTAUTOKW-UHFFFAOYSA-N 0.000 claims 4
- FYRCMPVHDQPOHS-UHFFFAOYSA-N 6-butyl-5-(2,6-dimethoxyphenyl)-3-[3-(4-fluorophenyl)pyrrolidine-1-carbonyl]-4-hydroxy-1H-pyridin-2-one Chemical compound C(CCC)C1=C(C(=C(C(=N1)O)C(=O)N1CC(CC1)C1=CC=C(C=C1)F)O)C1=C(C=CC=C1OC)OC FYRCMPVHDQPOHS-UHFFFAOYSA-N 0.000 claims 4
- PFURAOMBNMGHKV-UHFFFAOYSA-N 6-butyl-5-(2,6-dimethoxyphenyl)-3-[3-(5-fluoropyridin-2-yl)pyrrolidine-1-carbonyl]-4-hydroxy-1H-pyridin-2-one Chemical compound C(CCC)C1=C(C(=C(C(=N1)O)C(=O)N1CC(CC1)C1=NC=C(C=C1)F)O)C1=C(C=CC=C1OC)OC PFURAOMBNMGHKV-UHFFFAOYSA-N 0.000 claims 4
- 125000002837 carbocyclic group Chemical group 0.000 claims 4
- 125000005843 halogen group Chemical group 0.000 claims 4
- 150000002367 halogens Chemical class 0.000 claims 4
- 125000003003 spiro group Chemical group 0.000 claims 4
- GUFNVUDXTINVTO-UHFFFAOYSA-N 6-butyl-5-(2,6-dimethoxyphenyl)-4-hydroxy-3-[4-(3-propyl-1,2,4-oxadiazol-5-yl)piperidine-1-carbonyl]-1H-pyridin-2-one Chemical compound CCCCC1=C(C(O)=C(C(=O)N2CCC(CC2)C2=NC(CCC)=NO2)C(O)=N1)C1=C(OC)C=CC=C1OC GUFNVUDXTINVTO-UHFFFAOYSA-N 0.000 claims 3
- 206010019280 Heart failures Diseases 0.000 claims 3
- 125000005842 heteroatom Chemical group 0.000 claims 3
- 125000006706 (C3-C6) carbocyclyl group Chemical group 0.000 claims 2
- YEWCQODMEFGLMI-UHFFFAOYSA-N 1'-[6-butyl-5-(2,6-dimethoxyphenyl)-4-hydroxy-2-oxo-1H-pyridine-3-carbonyl]spiro[1,3-dihydroquinoline-4,4'-piperidine]-2-one Chemical compound C(CCC)C1=C(C(=C(C(=N1)O)C(=O)N1CCC2(CC(NC3=CC=CC=C23)=O)CC1)O)C1=C(C=CC=C1OC)OC YEWCQODMEFGLMI-UHFFFAOYSA-N 0.000 claims 2
- XYEOQMQNEUFXJB-UHFFFAOYSA-N 1'-[6-butyl-5-(2,6-dimethoxyphenyl)-4-hydroxy-2-oxo-1H-pyridine-3-carbonyl]spiro[1H-3,1-benzoxazine-4,4'-piperidine]-2-one Chemical compound C(CCC)C1=C(C(=C(C(=N1)O)C(=O)N1CCC2(CC1)OC(NC1=C2C=CC=C1)=O)O)C1=C(C=CC=C1OC)OC XYEOQMQNEUFXJB-UHFFFAOYSA-N 0.000 claims 2
- FRXYVYVLLWBSEB-UHFFFAOYSA-N 2-[3-[2-butyl-5-[4-[(2,3-difluorophenyl)methyl]piperazine-1-carbonyl]-4-hydroxy-6-oxo-1H-pyridin-3-yl]phenyl]acetonitrile Chemical compound C(CCC)C1=NC(=C(C(=C1C=1C=C(C=CC=1)CC#N)O)C(=O)N1CCN(CC1)CC1=C(C(=CC=C1)F)F)O FRXYVYVLLWBSEB-UHFFFAOYSA-N 0.000 claims 2
- XEOZTKITOZQOJR-UHFFFAOYSA-N 3-(2,6-dimethoxyphenyl)-4-hydroxy-1H-pyridin-2-one Chemical compound COC1=C(C(=CC=C1)OC)C=1C(=NC=CC=1O)O XEOZTKITOZQOJR-UHFFFAOYSA-N 0.000 claims 2
- RKAQGZNSSXXHGN-UHFFFAOYSA-N 3-(4-benzhydrylpiperazine-1-carbonyl)-6-butyl-5-(2,6-dimethoxyphenyl)-4-hydroxy-1H-pyridin-2-one Chemical compound C(CCC)C1=C(C(=C(C(=N1)O)C(=O)N1CCN(CC1)C(C1=CC=CC=C1)C1=CC=CC=C1)O)C1=C(C=CC=C1OC)OC RKAQGZNSSXXHGN-UHFFFAOYSA-N 0.000 claims 2
- QBRYZFLMFWWEOG-UHFFFAOYSA-N 3-(4-benzoylpiperazine-1-carbonyl)-6-butyl-5-(2,6-dimethoxyphenyl)-4-hydroxy-1H-pyridin-2-one Chemical compound C(C1=CC=CC=C1)(=O)N1CCN(CC1)C(=O)C=1C(=NC(=C(C=1O)C1=C(C=CC=C1OC)OC)CCCC)O QBRYZFLMFWWEOG-UHFFFAOYSA-N 0.000 claims 2
- VGLSSGXIWVAQGC-UHFFFAOYSA-N 3-(4-benzylpiperidine-1-carbonyl)-6-butyl-5-(2,6-dimethoxyphenyl)-4-hydroxy-1H-pyridin-2-one Chemical compound C(C1=CC=CC=C1)C1CCN(CC1)C(=O)C=1C(=NC(=C(C=1O)C1=C(C=CC=C1OC)OC)CCCC)O VGLSSGXIWVAQGC-UHFFFAOYSA-N 0.000 claims 2
- BEKNNWPDAWWCKK-UHFFFAOYSA-N 3-[3-(3,5-difluoropyridin-2-yl)pyrrolidine-1-carbonyl]-5-(2,6-dimethoxyphenyl)-6-(4-fluorophenyl)-4-hydroxy-1H-pyridin-2-one Chemical compound FC=1C(=NC=C(C=1)F)C1CN(CC1)C(=O)C=1C(=NC(=C(C=1O)C1=C(C=CC=C1OC)OC)C1=CC=C(C=C1)F)O BEKNNWPDAWWCKK-UHFFFAOYSA-N 0.000 claims 2
- HQQPPLDRRWXRLW-UHFFFAOYSA-N 3-[3-(3,5-difluoropyridin-2-yl)pyrrolidine-1-carbonyl]-5-(2,6-dimethoxyphenyl)-6-(ethoxymethyl)-4-hydroxy-1H-pyridin-2-one Chemical compound FC=1C(=NC=C(C=1)F)C1CN(CC1)C(=O)C=1C(=NC(=C(C=1O)C1=C(C=CC=C1OC)OC)COCC)O HQQPPLDRRWXRLW-UHFFFAOYSA-N 0.000 claims 2
- ZVIMEZNEMDYJPV-UHFFFAOYSA-N 3-[4-(1,2-benzothiazol-3-yl)piperazine-1-carbonyl]-6-butyl-5-(2,6-dimethoxyphenyl)-4-hydroxy-1H-pyridin-2-one Chemical compound S1N=C(C2=C1C=CC=C2)N1CCN(CC1)C(=O)C=1C(=NC(=C(C=1O)C1=C(C=CC=C1OC)OC)CCCC)O ZVIMEZNEMDYJPV-UHFFFAOYSA-N 0.000 claims 2
- QDSLOWFLSKKPFS-UHFFFAOYSA-N 3-[4-(1,3-benzothiazol-2-yl)piperazine-1-carbonyl]-6-butyl-5-(2,6-dimethoxyphenyl)-4-hydroxy-1H-pyridin-2-one Chemical compound S1C(=NC2=C1C=CC=C2)N1CCN(CC1)C(=O)C=1C(=NC(=C(C=1O)C1=C(C=CC=C1OC)OC)CCCC)O QDSLOWFLSKKPFS-UHFFFAOYSA-N 0.000 claims 2
- LEEJSVUKJKLOHX-UHFFFAOYSA-N 3-[4-(1,3-benzothiazol-2-yl)piperidine-1-carbonyl]-6-butyl-5-(2,6-dimethoxyphenyl)-4-hydroxy-1H-pyridin-2-one Chemical compound S1C(=NC2=C1C=CC=C2)C1CCN(CC1)C(=O)C=1C(=NC(=C(C=1O)C1=C(C=CC=C1OC)OC)CCCC)O LEEJSVUKJKLOHX-UHFFFAOYSA-N 0.000 claims 2
- QTMUHSVYJGYWNS-UHFFFAOYSA-N 3-[4-(1,3-benzoxazol-2-yl)piperidine-1-carbonyl]-6-butyl-5-(2,6-dimethoxyphenyl)-4-hydroxy-1H-pyridin-2-one Chemical compound O1C(=NC2=C1C=CC=C2)C1CCN(CC1)C(=O)C=1C(=NC(=C(C=1O)C1=C(C=CC=C1OC)OC)CCCC)O QTMUHSVYJGYWNS-UHFFFAOYSA-N 0.000 claims 2
- AGDFNJVHDNKBLX-UHFFFAOYSA-N 3-[4-[(2,3-dichlorophenyl)methyl]piperazine-1-carbonyl]-5-(2,6-dimethoxyphenyl)-6-(ethoxymethyl)-4-hydroxy-1H-pyridin-2-one Chemical compound ClC1=C(C=CC=C1Cl)CN1CCN(CC1)C(=O)C=1C(=NC(=C(C=1O)C1=C(C=CC=C1OC)OC)COCC)O AGDFNJVHDNKBLX-UHFFFAOYSA-N 0.000 claims 2
- WATKCBGABFQNRI-UHFFFAOYSA-N 3-[4-[(2,3-difluorophenyl)methyl]piperazine-1-carbonyl]-5-(2,6-dimethoxyphenyl)-6-(ethoxymethyl)-4-hydroxy-1H-pyridin-2-one Chemical compound FC1=C(C=CC=C1F)CN1CCN(CC1)C(=O)C=1C(=NC(=C(C=1O)C1=C(C=CC=C1OC)OC)COCC)O WATKCBGABFQNRI-UHFFFAOYSA-N 0.000 claims 2
- DIJRZAGOFDBDGX-UHFFFAOYSA-N 3-[4-[(2-bromo-5-fluorophenyl)methyl]piperidine-1-carbonyl]-6-butyl-5-(2,6-dimethoxyphenyl)-4-hydroxy-1H-pyridin-2-one Chemical compound BrC1=C(C=C(C=C1)F)CC1CCN(CC1)C(=O)C=1C(=NC(=C(C=1O)C1=C(C=CC=C1OC)OC)CCCC)O DIJRZAGOFDBDGX-UHFFFAOYSA-N 0.000 claims 2
- VRLNCNWNDNXTCM-UHFFFAOYSA-N 5-(2,6-dimethoxyphenyl)-3-[4-[(3-fluorophenyl)methyl]piperazine-1-carbonyl]-4-hydroxy-6-(2-methoxyethyl)-1H-pyridin-2-one Chemical compound COC1=C(C(=CC=C1)OC)C=1C(=C(C(=NC=1CCOC)O)C(=O)N1CCN(CC1)CC1=CC(=CC=C1)F)O VRLNCNWNDNXTCM-UHFFFAOYSA-N 0.000 claims 2
- SEXZYTNOKJFQTI-UHFFFAOYSA-N 5-(2,6-dimethoxyphenyl)-6-(ethoxymethyl)-3-[4-[(2-fluorophenyl)methyl]piperazine-1-carbonyl]-4-hydroxy-1H-pyridin-2-one Chemical compound COC1=C(C(=CC=C1)OC)C=1C(=C(C(=NC=1COCC)O)C(=O)N1CCN(CC1)CC1=C(C=CC=C1)F)O SEXZYTNOKJFQTI-UHFFFAOYSA-N 0.000 claims 2
- ZLRDNEZLCPNZKE-UHFFFAOYSA-N 5-(2,6-dimethoxyphenyl)-6-(ethoxymethyl)-3-[4-[(3-fluorophenyl)methyl]piperazine-1-carbonyl]-4-hydroxy-1H-pyridin-2-one Chemical compound COC1=C(C(=CC=C1)OC)C=1C(=C(C(=NC=1COCC)O)C(=O)N1CCN(CC1)CC1=CC(=CC=C1)F)O ZLRDNEZLCPNZKE-UHFFFAOYSA-N 0.000 claims 2
- MORAXWPILAFWAK-SFHVURJKSA-N 5-(2,6-dimethoxyphenyl)-6-(ethoxymethyl)-4-hydroxy-3-[(3R)-3-phenylpyrrolidine-1-carbonyl]-1H-pyridin-2-one Chemical compound COC1=C(C(=CC=C1)OC)C=1C(=C(C(=NC=1COCC)O)C(=O)N1C[C@H](CC1)C1=CC=CC=C1)O MORAXWPILAFWAK-SFHVURJKSA-N 0.000 claims 2
- ZLNULAJDQCJLOL-IBGZPJMESA-N 5-(2,6-dimethoxyphenyl)-6-(ethoxymethyl)-4-hydroxy-3-[(3S)-3-phenylmethoxypyrrolidine-1-carbonyl]-1H-pyridin-2-one Chemical compound C(C1=CC=CC=C1)O[C@@H]1CN(CC1)C(=O)C=1C(=NC(=C(C=1O)C1=C(C=CC=C1OC)OC)COCC)O ZLNULAJDQCJLOL-IBGZPJMESA-N 0.000 claims 2
- MORAXWPILAFWAK-GOSISDBHSA-N 5-(2,6-dimethoxyphenyl)-6-(ethoxymethyl)-4-hydroxy-3-[(3S)-3-phenylpyrrolidine-1-carbonyl]-1H-pyridin-2-one Chemical compound COC1=C(C(=CC=C1)OC)C=1C(=C(C(=NC=1COCC)O)C(=O)N1C[C@@H](CC1)C1=CC=CC=C1)O MORAXWPILAFWAK-GOSISDBHSA-N 0.000 claims 2
- IQRUQXXCIDNXLO-UHFFFAOYSA-N 5-(2,6-dimethoxyphenyl)-6-(ethylaminomethyl)-3-[3-(3-fluorophenyl)pyrrolidine-1-carbonyl]-4-hydroxy-1H-pyridin-2-one Chemical compound COC1=C(C(=CC=C1)OC)C=1C(=C(C(=NC=1CNCC)O)C(=O)N1CC(CC1)C1=CC(=CC=C1)F)O IQRUQXXCIDNXLO-UHFFFAOYSA-N 0.000 claims 2
- UAHUYSRHLWEMMI-UHFFFAOYSA-N 6-(ethoxymethyl)-3-[4-[(3-fluorophenyl)methyl]piperazine-1-carbonyl]-4-hydroxy-5-(2-methoxyphenyl)-1H-pyridin-2-one Chemical compound C(C)OCC1=C(C(=C(C(=N1)O)C(=O)N1CCN(CC1)CC1=CC(=CC=C1)F)O)C1=C(C=CC=C1)OC UAHUYSRHLWEMMI-UHFFFAOYSA-N 0.000 claims 2
- QSHXHZFCIYLKBU-UHFFFAOYSA-N 6-butyl-3-(4-cyclohexylpiperazine-1-carbonyl)-5-(2,6-dimethoxyphenyl)-4-hydroxy-1H-pyridin-2-one Chemical compound C(CCC)C1=C(C(=C(C(=N1)O)C(=O)N1CCN(CC1)C1CCCCC1)O)C1=C(C=CC=C1OC)OC QSHXHZFCIYLKBU-UHFFFAOYSA-N 0.000 claims 2
- DBUHEXRTLWRNBS-UHFFFAOYSA-N 6-butyl-3-[3-(3,5-difluoropyridin-2-yl)pyrrolidine-1-carbonyl]-4-hydroxy-5-(3-propan-2-ylphenyl)-1H-pyridin-2-one Chemical compound C(CCC)C1=C(C(=C(C(=N1)O)C(=O)N1CC(CC1)C1=NC=C(C=C1F)F)O)C1=CC(=CC=C1)C(C)C DBUHEXRTLWRNBS-UHFFFAOYSA-N 0.000 claims 2
- ZKJPREGZORLOPY-UHFFFAOYSA-N 6-butyl-3-[3-(3-chlorophenyl)azetidine-1-carbonyl]-5-(2,6-dimethoxyphenyl)-4-hydroxy-1H-pyridin-2-one Chemical compound C(CCC)C1=C(C(=C(C(=N1)O)C(=O)N1CC(C1)C1=CC(=CC=C1)Cl)O)C1=C(C=CC=C1OC)OC ZKJPREGZORLOPY-UHFFFAOYSA-N 0.000 claims 2
- VWJYLLQLCPPMLL-UHFFFAOYSA-N 6-butyl-3-[3-[(2,3-difluorophenyl)methoxy]azetidine-1-carbonyl]-5-(2,6-dimethoxyphenyl)-4-hydroxy-1H-pyridin-2-one Chemical compound C(CCC)C1=C(C(=C(C(=N1)O)C(=O)N1CC(C1)OCC1=C(C(=CC=C1)F)F)O)C1=C(C=CC=C1OC)OC VWJYLLQLCPPMLL-UHFFFAOYSA-N 0.000 claims 2
- MYVXXFTUMSCSBA-UHFFFAOYSA-N 6-butyl-3-[3-[4-(2-chloro-4-methoxy-5-methylphenyl)-5-methyl-1,3-thiazol-2-yl]pyrrolidine-1-carbonyl]-5-(2,6-dimethoxyphenyl)-4-hydroxy-1H-pyridin-2-one Chemical compound CCCCC1=C(C(O)=C(C(=O)N2CCC(C2)C2=NC(=C(C)S2)C2=C(Cl)C=C(OC)C(C)=C2)C(O)=N1)C1=C(OC)C=CC=C1OC MYVXXFTUMSCSBA-UHFFFAOYSA-N 0.000 claims 2
- BYBOHPULIGDKJB-UHFFFAOYSA-N 6-butyl-3-[4-(2,3-dichlorobenzoyl)piperazine-1-carbonyl]-5-(2,6-dimethoxyphenyl)-4-hydroxy-1H-pyridin-2-one Chemical compound C(CCC)C1=C(C(=C(C(=N1)O)C(=O)N1CCN(CC1)C(C1=C(C(=CC=C1)Cl)Cl)=O)O)C1=C(C=CC=C1OC)OC BYBOHPULIGDKJB-UHFFFAOYSA-N 0.000 claims 2
- IDNNPXOEIGAVEZ-UHFFFAOYSA-N 6-butyl-3-[4-(2,3-difluorobenzoyl)piperazine-1-carbonyl]-5-(2,6-dimethoxyphenyl)-4-hydroxy-1H-pyridin-2-one Chemical compound C(CCC)C1=C(C(=C(C(=N1)O)C(=O)N1CCN(CC1)C(C1=C(C(=CC=C1)F)F)=O)O)C1=C(C=CC=C1OC)OC IDNNPXOEIGAVEZ-UHFFFAOYSA-N 0.000 claims 2
- LQCZWCZUQUOOTK-UHFFFAOYSA-N 6-butyl-3-[4-(2-chlorophenyl)piperazine-1-carbonyl]-5-(2,6-dimethoxyphenyl)-4-hydroxy-1H-pyridin-2-one Chemical compound C(CCC)C1=C(C(=C(C(=N1)O)C(=O)N1CCN(CC1)C1=C(C=CC=C1)Cl)O)C1=C(C=CC=C1OC)OC LQCZWCZUQUOOTK-UHFFFAOYSA-N 0.000 claims 2
- GUJCGYYABOOGPH-UHFFFAOYSA-N 6-butyl-3-[4-(2-chlorophenyl)piperidine-1-carbonyl]-5-(2,6-dimethoxyphenyl)-4-hydroxy-1H-pyridin-2-one Chemical compound C(CCC)C1=C(C(=C(C(=N1)O)C(=O)N1CCC(CC1)C1=C(C=CC=C1)Cl)O)C1=C(C=CC=C1OC)OC GUJCGYYABOOGPH-UHFFFAOYSA-N 0.000 claims 2
- UFEZPTRCDRMMHG-UHFFFAOYSA-N 6-butyl-3-[4-(3-chlorophenyl)piperazine-1-carbonyl]-5-(2,6-dimethoxyphenyl)-4-hydroxy-1H-pyridin-2-one Chemical compound C(CCC)C1=C(C(=C(C(=N1)O)C(=O)N1CCN(CC1)C1=CC(=CC=C1)Cl)O)C1=C(C=CC=C1OC)OC UFEZPTRCDRMMHG-UHFFFAOYSA-N 0.000 claims 2
- MCQBRBORRICOPD-UHFFFAOYSA-N 6-butyl-3-[4-(3-chlorophenyl)piperidine-1-carbonyl]-5-(2,6-dimethoxyphenyl)-4-hydroxy-1H-pyridin-2-one Chemical compound C(CCC)C1=C(C(=C(C(=N1)O)C(=O)N1CCC(CC1)C1=CC(=CC=C1)Cl)O)C1=C(C=CC=C1OC)OC MCQBRBORRICOPD-UHFFFAOYSA-N 0.000 claims 2
- TZFFAXXOWWNCHB-UHFFFAOYSA-N 6-butyl-3-[4-(4-chlorophenyl)-4-hydroxypiperidine-1-carbonyl]-5-(2,6-dimethoxyphenyl)-4-hydroxy-1H-pyridin-2-one Chemical compound C(CCC)C1=C(C(=C(C(=N1)O)C(=O)N1CCC(CC1)(O)C1=CC=C(C=C1)Cl)O)C1=C(C=CC=C1OC)OC TZFFAXXOWWNCHB-UHFFFAOYSA-N 0.000 claims 2
- CJTHQTYFUMVVRG-UHFFFAOYSA-N 6-butyl-3-[4-(4-chlorophenyl)piperazine-1-carbonyl]-5-(2,6-dimethoxyphenyl)-4-hydroxy-1H-pyridin-2-one Chemical compound C(CCC)C1=C(C(=C(C(=N1)O)C(=O)N1CCN(CC1)C1=CC=C(C=C1)Cl)O)C1=C(C=CC=C1OC)OC CJTHQTYFUMVVRG-UHFFFAOYSA-N 0.000 claims 2
- QAVTXIWGNKLILT-UHFFFAOYSA-N 6-butyl-3-[4-(5-chloropyridin-2-yl)oxypiperidine-1-carbonyl]-5-(2,6-dimethoxyphenyl)-4-hydroxy-1H-pyridin-2-one Chemical compound C(CCC)C1=C(C(=C(C(=N1)O)C(=O)N1CCC(CC1)OC1=NC=C(C=C1)Cl)O)C1=C(C=CC=C1OC)OC QAVTXIWGNKLILT-UHFFFAOYSA-N 0.000 claims 2
- LAFGAVGKUPAUJF-UHFFFAOYSA-N 6-butyl-3-[4-(5-chloropyridine-2-carbonyl)piperazine-1-carbonyl]-5-(2,6-dimethoxyphenyl)-4-hydroxy-1H-pyridin-2-one Chemical compound C(CCC)C1=C(C(=C(C(=N1)O)C(=O)N1CCN(CC1)C(=O)C1=NC=C(C=C1)Cl)O)C1=C(C=CC=C1OC)OC LAFGAVGKUPAUJF-UHFFFAOYSA-N 0.000 claims 2
- SLXDSRXVIGBRNZ-UHFFFAOYSA-N 6-butyl-3-[4-(cyclohexylmethyl)piperazine-1-carbonyl]-5-(2,6-dimethoxyphenyl)-4-hydroxy-1H-pyridin-2-one Chemical compound C(CCC)C1=C(C(=C(C(=N1)O)C(=O)N1CCN(CC1)CC1CCCCC1)O)C1=C(C=CC=C1OC)OC SLXDSRXVIGBRNZ-UHFFFAOYSA-N 0.000 claims 2
- RWSAPGOQPPRPTF-UHFFFAOYSA-N 6-butyl-3-[4-(cyclopropylmethyl)piperazine-1-carbonyl]-5-(2,6-dimethoxyphenyl)-4-hydroxy-1H-pyridin-2-one Chemical compound C(CCC)C1=C(C(=C(C(=N1)O)C(=O)N1CCN(CC1)CC1CC1)O)C1=C(C=CC=C1OC)OC RWSAPGOQPPRPTF-UHFFFAOYSA-N 0.000 claims 2
- UGIXRSNRUXSCID-UHFFFAOYSA-N 6-butyl-3-[4-[(2,3-dichlorophenyl)methyl]piperazine-1-carbonyl]-5-(2,3-dimethoxyphenyl)-4-hydroxy-1H-pyridin-2-one Chemical compound C(CCC)C1=C(C(=C(C(=N1)O)C(=O)N1CCN(CC1)CC1=C(C(=CC=C1)Cl)Cl)O)C1=C(C(=CC=C1)OC)OC UGIXRSNRUXSCID-UHFFFAOYSA-N 0.000 claims 2
- FHZCKUYQJUXHPH-UHFFFAOYSA-N 6-butyl-3-[4-[(2,3-dichlorophenyl)methyl]piperazine-1-carbonyl]-5-(2,5-dimethoxyphenyl)-4-hydroxy-1H-pyridin-2-one Chemical compound C(CCC)C1=C(C(=C(C(=N1)O)C(=O)N1CCN(CC1)CC1=C(C(=CC=C1)Cl)Cl)O)C1=C(C=CC(=C1)OC)OC FHZCKUYQJUXHPH-UHFFFAOYSA-N 0.000 claims 2
- UPWPJDUMNWHYHZ-UHFFFAOYSA-N 6-butyl-3-[4-[(2,3-dichlorophenyl)methyl]piperazine-1-carbonyl]-5-(2,6-dimethoxyphenyl)-4-hydroxy-1H-pyridin-2-one Chemical compound C(CCC)C1=C(C(=C(C(=N1)O)C(=O)N1CCN(CC1)CC1=C(C(=CC=C1)Cl)Cl)O)C1=C(C=CC=C1OC)OC UPWPJDUMNWHYHZ-UHFFFAOYSA-N 0.000 claims 2
- FHUQYVQCIQJAHF-UHFFFAOYSA-N 6-butyl-3-[4-[(2,3-difluorophenyl)methyl]piperazine-1-carbonyl]-5-(2,3-dimethoxyphenyl)-4-hydroxy-1H-pyridin-2-one Chemical compound C(CCC)C1=C(C(=C(C(=N1)O)C(=O)N1CCN(CC1)CC1=C(C(=CC=C1)F)F)O)C1=C(C(=CC=C1)OC)OC FHUQYVQCIQJAHF-UHFFFAOYSA-N 0.000 claims 2
- FFORQQRXYATGPS-UHFFFAOYSA-N 6-butyl-3-[4-[(2,3-difluorophenyl)methyl]piperazine-1-carbonyl]-5-(2,5-dimethoxyphenyl)-4-hydroxy-1H-pyridin-2-one Chemical compound C(CCC)C1=C(C(=C(C(=N1)O)C(=O)N1CCN(CC1)CC1=C(C(=CC=C1)F)F)O)C1=C(C=CC(=C1)OC)OC FFORQQRXYATGPS-UHFFFAOYSA-N 0.000 claims 2
- GVUYOSRUKWPPQX-UHFFFAOYSA-N 6-butyl-3-[4-[(2,3-difluorophenyl)methyl]piperazine-1-carbonyl]-5-(2,6-dimethoxyphenyl)-4-hydroxy-1H-pyridin-2-one Chemical compound C(CCC)C1=C(C(=C(C(=N1)O)C(=O)N1CCN(CC1)CC1=C(C(=CC=C1)F)F)O)C1=C(C=CC=C1OC)OC GVUYOSRUKWPPQX-UHFFFAOYSA-N 0.000 claims 2
- SYJZPHVLKKFXOW-UHFFFAOYSA-N 6-butyl-3-[4-[(2,4-dichlorophenyl)methyl]piperazine-1-carbonyl]-5-(2,6-dimethoxyphenyl)-4-hydroxy-1H-pyridin-2-one Chemical compound C(CCC)C1=C(C(=C(C(=N1)O)C(=O)N1CCN(CC1)CC1=C(C=C(C=C1)Cl)Cl)O)C1=C(C=CC=C1OC)OC SYJZPHVLKKFXOW-UHFFFAOYSA-N 0.000 claims 2
- OHBYNROWBKOKQX-UHFFFAOYSA-N 6-butyl-3-[4-[(2,5-difluorophenyl)methyl]piperazine-1-carbonyl]-5-(2,6-dimethoxyphenyl)-4-hydroxy-1H-pyridin-2-one Chemical compound C(CCC)C1=C(C(=C(C(=N1)O)C(=O)N1CCN(CC1)CC1=C(C=CC(=C1)F)F)O)C1=C(C=CC=C1OC)OC OHBYNROWBKOKQX-UHFFFAOYSA-N 0.000 claims 2
- BFAVJIZCJXSCMR-UHFFFAOYSA-N 6-butyl-3-[4-[(4-chlorophenyl)methyl]piperazine-1-carbonyl]-5-(2,6-dimethoxyphenyl)-4-hydroxy-1H-pyridin-2-one Chemical compound C(CCC)C1=C(C(=C(C(=N1)O)C(=O)N1CCN(CC1)CC1=CC=C(C=C1)Cl)O)C1=C(C=CC=C1OC)OC BFAVJIZCJXSCMR-UHFFFAOYSA-N 0.000 claims 2
- QQFKIIYPEGDIRN-UHFFFAOYSA-N 6-butyl-3-[4-[(6-chloropyridin-2-yl)methyl]piperazine-1-carbonyl]-5-(2,6-dimethoxyphenyl)-4-hydroxy-1H-pyridin-2-one Chemical compound C(CCC)C1=C(C(=C(C(=N1)O)C(=O)N1CCN(CC1)CC1=NC(=CC=C1)Cl)O)C1=C(C=CC=C1OC)OC QQFKIIYPEGDIRN-UHFFFAOYSA-N 0.000 claims 2
- RUJHNKADQHZZDS-QHCPKHFHSA-N 6-butyl-4-hydroxy-3-[(3R)-3-phenylpyrrolidine-1-carbonyl]-5-(3-propan-2-ylphenyl)-1H-pyridin-2-one Chemical compound C(CCC)C1=C(C(=C(C(=N1)O)C(=O)N1C[C@H](CC1)C1=CC=CC=C1)O)C1=CC(=CC=C1)C(C)C RUJHNKADQHZZDS-QHCPKHFHSA-N 0.000 claims 2
- KPIKYAWKTFSLOT-IBGZPJMESA-N 6-butyl-5-(2,5-dimethoxyphenyl)-4-hydroxy-3-[(3R)-3-phenylpyrrolidine-1-carbonyl]-1H-pyridin-2-one Chemical compound C(CCC)C1=C(C(=C(C(=N1)O)C(=O)N1C[C@H](CC1)C1=CC=CC=C1)O)C1=C(C=CC(=C1)OC)OC KPIKYAWKTFSLOT-IBGZPJMESA-N 0.000 claims 2
- KPIKYAWKTFSLOT-LJQANCHMSA-N 6-butyl-5-(2,5-dimethoxyphenyl)-4-hydroxy-3-[(3S)-3-phenylpyrrolidine-1-carbonyl]-1H-pyridin-2-one Chemical compound C(CCC)C1=C(C(=C(C(=N1)O)C(=O)N1C[C@@H](CC1)C1=CC=CC=C1)O)C1=C(C=CC(=C1)OC)OC KPIKYAWKTFSLOT-LJQANCHMSA-N 0.000 claims 2
- IHOOFLBEFRNISQ-UHFFFAOYSA-N 6-butyl-5-(2,6-dimethoxyphenyl)-3-[3-(3-fluoropyridin-2-yl)oxyazetidine-1-carbonyl]-4-hydroxy-1H-pyridin-2-one Chemical compound C(CCC)C1=C(C(=C(C(=N1)O)C(=O)N1CC(C1)OC1=NC=CC=C1F)O)C1=C(C=CC=C1OC)OC IHOOFLBEFRNISQ-UHFFFAOYSA-N 0.000 claims 2
- ARDLEWAHEZITSD-UHFFFAOYSA-N 6-butyl-5-(2,6-dimethoxyphenyl)-3-[4-(3-fluorobenzoyl)piperazine-1-carbonyl]-4-hydroxy-1H-pyridin-2-one Chemical compound C(CCC)C1=C(C(=C(C(=N1)O)C(=O)N1CCN(CC1)C(C1=CC(=CC=C1)F)=O)O)C1=C(C=CC=C1OC)OC ARDLEWAHEZITSD-UHFFFAOYSA-N 0.000 claims 2
- TYORUNWNAGCDHA-UHFFFAOYSA-N 6-butyl-5-(2,6-dimethoxyphenyl)-3-[4-[(2-fluoro-3-methylphenyl)methyl]piperazine-1-carbonyl]-4-hydroxy-1H-pyridin-2-one Chemical compound C(CCC)C1=C(C(=C(C(=N1)O)C(=O)N1CCN(CC1)CC1=C(C(=CC=C1)C)F)O)C1=C(C=CC=C1OC)OC TYORUNWNAGCDHA-UHFFFAOYSA-N 0.000 claims 2
- WNKUPNMMDVIAJD-UHFFFAOYSA-N 6-butyl-5-(2,6-dimethoxyphenyl)-3-[4-[(2-fluorophenyl)methyl]piperazine-1-carbonyl]-4-hydroxy-1H-pyridin-2-one Chemical compound C(CCC)C1=C(C(=C(C(=N1)O)C(=O)N1CCN(CC1)CC1=C(C=CC=C1)F)O)C1=C(C=CC=C1OC)OC WNKUPNMMDVIAJD-UHFFFAOYSA-N 0.000 claims 2
- GUFPHRJNZDHUQT-UHFFFAOYSA-N 6-butyl-5-(2,6-dimethoxyphenyl)-3-[4-[(3-fluorophenyl)methyl]piperazine-1-carbonyl]-4-hydroxy-1H-pyridin-2-one Chemical compound C(CCC)C1=C(C(=C(C(=N1)O)C(=O)N1CCN(CC1)CC1=CC(=CC=C1)F)O)C1=C(C=CC=C1OC)OC GUFPHRJNZDHUQT-UHFFFAOYSA-N 0.000 claims 2
- PQKJBACOPZUZLR-UHFFFAOYSA-N 6-butyl-5-(2,6-dimethoxyphenyl)-3-[4-[(3-fluoropyridin-2-yl)methyl]piperazine-1-carbonyl]-4-hydroxy-1H-pyridin-2-one Chemical compound C(CCC)C1=C(C(=C(C(=N1)O)C(=O)N1CCN(CC1)CC1=NC=CC=C1F)O)C1=C(C=CC=C1OC)OC PQKJBACOPZUZLR-UHFFFAOYSA-N 0.000 claims 2
- XIKCVOQQGJCBPC-UHFFFAOYSA-N 6-butyl-5-(2,6-dimethoxyphenyl)-3-[4-[(4-fluorophenyl)methyl]piperazine-1-carbonyl]-4-hydroxy-1H-pyridin-2-one Chemical compound C(CCC)C1=C(C(=C(C(=N1)O)C(=O)N1CCN(CC1)CC1=CC=C(C=C1)F)O)C1=C(C=CC=C1OC)OC XIKCVOQQGJCBPC-UHFFFAOYSA-N 0.000 claims 2
- CVSDIBBHLQRBTO-UHFFFAOYSA-N 6-butyl-5-(2,6-dimethoxyphenyl)-4-hydroxy-3-(2-pyridin-2-ylpyrrolidine-1-carbonyl)-1H-pyridin-2-one Chemical compound C(CCC)C1=C(C(=C(C(=N1)O)C(=O)N1C(CCC1)C1=NC=CC=C1)O)C1=C(C=CC=C1OC)OC CVSDIBBHLQRBTO-UHFFFAOYSA-N 0.000 claims 2
- SYXJHTYOLFBZRR-UHFFFAOYSA-N 6-butyl-5-(2,6-dimethoxyphenyl)-4-hydroxy-3-(4-hydroxy-4-phenylpiperidine-1-carbonyl)-1H-pyridin-2-one Chemical compound C(CCC)C1=C(C(=C(C(=N1)O)C(=O)N1CCC(CC1)(C1=CC=CC=C1)O)O)C1=C(C=CC=C1OC)OC SYXJHTYOLFBZRR-UHFFFAOYSA-N 0.000 claims 2
- FOWGPJMHFKCABB-UHFFFAOYSA-N 6-butyl-5-(2,6-dimethoxyphenyl)-4-hydroxy-3-(4-hydroxy-4-pyridin-3-ylpiperidine-1-carbonyl)-1H-pyridin-2-one Chemical compound C(CCC)C1=C(C(=C(C(=N1)O)C(=O)N1CCC(CC1)(C=1C=NC=CC=1)O)O)C1=C(C=CC=C1OC)OC FOWGPJMHFKCABB-UHFFFAOYSA-N 0.000 claims 2
- CIWWBPQENDKOJE-UHFFFAOYSA-N 6-butyl-5-(2,6-dimethoxyphenyl)-4-hydroxy-3-(4-phenoxypiperidine-1-carbonyl)-1H-pyridin-2-one Chemical compound C(CCC)C1=C(C(=C(C(=N1)O)C(=O)N1CCC(CC1)OC1=CC=CC=C1)O)C1=C(C=CC=C1OC)OC CIWWBPQENDKOJE-UHFFFAOYSA-N 0.000 claims 2
- PEWYHEGDTYBPSA-UHFFFAOYSA-N 6-butyl-5-(2,6-dimethoxyphenyl)-4-hydroxy-3-(4-phenylpiperazine-1-carbonyl)-1H-pyridin-2-one Chemical compound C(CCC)C1=C(C(=C(C(=N1)O)C(=O)N1CCN(CC1)C1=CC=CC=C1)O)C1=C(C=CC=C1OC)OC PEWYHEGDTYBPSA-UHFFFAOYSA-N 0.000 claims 2
- QUKFQELSHHQCEQ-UHFFFAOYSA-N 6-butyl-5-(2,6-dimethoxyphenyl)-4-hydroxy-3-(4-phenylpiperidine-1-carbonyl)-1H-pyridin-2-one Chemical compound C(CCC)C1=C(C(=C(C(=N1)O)C(=O)N1CCC(CC1)C1=CC=CC=C1)O)C1=C(C=CC=C1OC)OC QUKFQELSHHQCEQ-UHFFFAOYSA-N 0.000 claims 2
- GNWHXORETIYCQZ-UHFFFAOYSA-N 6-butyl-5-(2,6-dimethoxyphenyl)-4-hydroxy-3-(4-pyridazin-3-ylpiperazine-1-carbonyl)-1H-pyridin-2-one Chemical compound C(CCC)C1=C(C(=C(C(=N1)O)C(=O)N1CCN(CC1)C=1N=NC=CC=1)O)C1=C(C=CC=C1OC)OC GNWHXORETIYCQZ-UHFFFAOYSA-N 0.000 claims 2
- OPHWKTZOOCUDAI-UHFFFAOYSA-N 6-butyl-5-(2,6-dimethoxyphenyl)-4-hydroxy-3-(4-pyridin-2-ylpiperazine-1-carbonyl)-1H-pyridin-2-one Chemical compound C(CCC)C1=C(C(=C(C(=N1)O)C(=O)N1CCN(CC1)C1=NC=CC=C1)O)C1=C(C=CC=C1OC)OC OPHWKTZOOCUDAI-UHFFFAOYSA-N 0.000 claims 2
- KQRRAIWYFKBTNV-UHFFFAOYSA-N 6-butyl-5-(2,6-dimethoxyphenyl)-4-hydroxy-3-(4-pyridin-4-ylpiperazine-1-carbonyl)-1H-pyridin-2-one Chemical compound C(CCC)C1=C(C(=C(C(=N1)O)C(=O)N1CCN(CC1)C1=CC=NC=C1)O)C1=C(C=CC=C1OC)OC KQRRAIWYFKBTNV-UHFFFAOYSA-N 0.000 claims 2
- TWCXIZHJKPRIMU-UHFFFAOYSA-N 6-butyl-5-(2,6-dimethoxyphenyl)-4-hydroxy-3-(4-pyrrolidin-1-ylpiperidine-1-carbonyl)-1H-pyridin-2-one Chemical compound C(CCC)C1=C(C(=C(C(=N1)O)C(=O)N1CCC(CC1)N1CCCC1)O)C1=C(C=CC=C1OC)OC TWCXIZHJKPRIMU-UHFFFAOYSA-N 0.000 claims 2
- BCINEYMTISNZFK-IBGZPJMESA-N 6-butyl-5-(2,6-dimethoxyphenyl)-4-hydroxy-3-[(3R)-3-phenylpyrrolidine-1-carbonyl]-1H-pyridin-2-one Chemical compound C(CCC)C1=C(C(=C(C(=N1)O)C(=O)N1C[C@H](CC1)C1=CC=CC=C1)O)C1=C(C=CC=C1OC)OC BCINEYMTISNZFK-IBGZPJMESA-N 0.000 claims 2
- ICXTZXJQTUBVHO-FQEVSTJZSA-N 6-butyl-5-(2,6-dimethoxyphenyl)-4-hydroxy-3-[(3S)-3-phenylmethoxypyrrolidine-1-carbonyl]-1H-pyridin-2-one Chemical compound C(C1=CC=CC=C1)O[C@@H]1CN(CC1)C(=O)C=1C(=NC(=C(C=1O)C1=C(C=CC=C1OC)OC)CCCC)O ICXTZXJQTUBVHO-FQEVSTJZSA-N 0.000 claims 2
- BCINEYMTISNZFK-LJQANCHMSA-N 6-butyl-5-(2,6-dimethoxyphenyl)-4-hydroxy-3-[(3S)-3-phenylpyrrolidine-1-carbonyl]-1H-pyridin-2-one Chemical compound C(CCC)C1=C(C(=C(C(=N1)O)C(=O)N1C[C@@H](CC1)C1=CC=CC=C1)O)C1=C(C=CC=C1OC)OC BCINEYMTISNZFK-LJQANCHMSA-N 0.000 claims 2
- OWDFUXRQUNAXRE-UHFFFAOYSA-N 6-butyl-5-(2,6-dimethoxyphenyl)-4-hydroxy-3-[4-(1-methylimidazol-2-yl)piperazine-1-carbonyl]-1H-pyridin-2-one Chemical compound C(CCC)C1=C(C(=C(C(=N1)O)C(=O)N1CCN(CC1)C=1N(C=CN=1)C)O)C1=C(C=CC=C1OC)OC OWDFUXRQUNAXRE-UHFFFAOYSA-N 0.000 claims 2
- KUGVUTDBIPOBKB-UHFFFAOYSA-N 6-butyl-5-(2,6-dimethoxyphenyl)-4-hydroxy-3-[4-(1-phenyltetrazol-5-yl)-1,4-diazepane-1-carbonyl]-1H-pyridin-2-one Chemical compound CCCCC1=C(C(O)=C(C(=O)N2CCCN(CC2)C2=NN=NN2C2=CC=CC=C2)C(O)=N1)C1=C(OC)C=CC=C1OC KUGVUTDBIPOBKB-UHFFFAOYSA-N 0.000 claims 2
- YTGFIQJVXSNSSP-UHFFFAOYSA-N 6-butyl-5-(2,6-dimethoxyphenyl)-4-hydroxy-3-[4-(1-phenyltetrazol-5-yl)piperazine-1-carbonyl]-1H-pyridin-2-one Chemical compound CCCCC1=C(C(O)=C(C(=O)N2CCN(CC2)C2=NN=NN2C2=CC=CC=C2)C(O)=N1)C1=C(OC)C=CC=C1OC YTGFIQJVXSNSSP-UHFFFAOYSA-N 0.000 claims 2
- BAZAHPWKZBAPMC-UHFFFAOYSA-N 6-butyl-5-(2,6-dimethoxyphenyl)-4-hydroxy-3-[4-(1H-imidazol-5-yl)piperidine-1-carbonyl]-1H-pyridin-2-one Chemical compound C(CCC)C1=C(C(=C(C(=N1)O)C(=O)N1CCC(CC1)C=1N=CNC=1)O)C1=C(C=CC=C1OC)OC BAZAHPWKZBAPMC-UHFFFAOYSA-N 0.000 claims 2
- ZWNOKHBGOOUECG-UHFFFAOYSA-N 6-butyl-5-(2,6-dimethoxyphenyl)-4-hydroxy-3-[4-(2-methoxyphenyl)piperazine-1-carbonyl]-1H-pyridin-2-one Chemical compound C(CCC)C1=C(C(=C(C(=N1)O)C(=O)N1CCN(CC1)C1=C(C=CC=C1)OC)O)C1=C(C=CC=C1OC)OC ZWNOKHBGOOUECG-UHFFFAOYSA-N 0.000 claims 2
- IMPRQMRJIGCQIP-UHFFFAOYSA-N 6-butyl-5-(2,6-dimethoxyphenyl)-4-hydroxy-3-[4-(2-methoxyphenyl)piperidine-1-carbonyl]-1H-pyridin-2-one Chemical compound C(CCC)C1=C(C(=C(C(=N1)O)C(=O)N1CCC(CC1)C1=C(C=CC=C1)OC)O)C1=C(C=CC=C1OC)OC IMPRQMRJIGCQIP-UHFFFAOYSA-N 0.000 claims 2
- FWWZHDLTYGYTSF-UHFFFAOYSA-N 6-butyl-5-(2,6-dimethoxyphenyl)-4-hydroxy-3-[4-(3-phenyl-1,2,4-thiadiazol-5-yl)piperazine-1-carbonyl]-1H-pyridin-2-one Chemical compound CCCCC1=C(C(O)=C(C(=O)N2CCN(CC2)C2=NC(=NS2)C2=CC=CC=C2)C(O)=N1)C1=C(OC)C=CC=C1OC FWWZHDLTYGYTSF-UHFFFAOYSA-N 0.000 claims 2
- MDMUEVODCXNPTO-UHFFFAOYSA-N 6-butyl-5-(2,6-dimethoxyphenyl)-4-hydroxy-3-[4-(3-phenyl-1H-pyrazol-5-yl)piperidine-1-carbonyl]-1H-pyridin-2-one Chemical compound C(CCC)C1=C(C(=C(C(=N1)O)C(=O)N1CCC(CC1)C1=NNC(=C1)C1=CC=CC=C1)O)C1=C(C=CC=C1OC)OC MDMUEVODCXNPTO-UHFFFAOYSA-N 0.000 claims 2
- ZNJZUGNJQLLHRU-UHFFFAOYSA-N 6-butyl-5-(2,6-dimethoxyphenyl)-4-hydroxy-3-[4-(3-pyridin-3-yl-1,2,4-oxadiazol-5-yl)piperidine-1-carbonyl]-1H-pyridin-2-one Chemical compound CCCCC1=C(C(O)=C(C(=O)N2CCC(CC2)C2=NC(=NO2)C2=CC=CN=C2)C(O)=N1)C1=C(OC)C=CC=C1OC ZNJZUGNJQLLHRU-UHFFFAOYSA-N 0.000 claims 2
- HDADEMFJXRAUJB-UHFFFAOYSA-N 6-butyl-5-(2,6-dimethoxyphenyl)-4-hydroxy-3-[4-(4-methoxybenzoyl)piperazine-1-carbonyl]-1H-pyridin-2-one Chemical compound C(CCC)C1=C(C(=C(C(=N1)O)C(=O)N1CCN(CC1)C(C1=CC=C(C=C1)OC)=O)O)C1=C(C=CC=C1OC)OC HDADEMFJXRAUJB-UHFFFAOYSA-N 0.000 claims 2
- UNMQUACFIABFAY-UHFFFAOYSA-N 6-butyl-5-(2,6-dimethoxyphenyl)-4-hydroxy-3-[4-(4-methoxyphenyl)piperazine-1-carbonyl]-1H-pyridin-2-one Chemical compound C(CCC)C1=C(C(=C(C(=N1)O)C(=O)N1CCN(CC1)C1=CC=C(C=C1)OC)O)C1=C(C=CC=C1OC)OC UNMQUACFIABFAY-UHFFFAOYSA-N 0.000 claims 2
- WROQXFPQWUNIQF-UHFFFAOYSA-N 6-butyl-5-(2,6-dimethoxyphenyl)-4-hydroxy-3-[4-(5-methyl-1H-imidazol-4-yl)piperidine-1-carbonyl]-1H-pyridin-2-one Chemical compound C(CCC)C1=C(C(=C(C(=N1)O)C(=O)N1CCC(CC1)C1=C(N=CN1)C)O)C1=C(C=CC=C1OC)OC WROQXFPQWUNIQF-UHFFFAOYSA-N 0.000 claims 2
- WEUGCKQKZYZKNZ-UHFFFAOYSA-N 6-butyl-5-(2,6-dimethoxyphenyl)-4-hydroxy-3-[4-(pyridin-2-ylmethyl)piperazine-1-carbonyl]-1H-pyridin-2-one Chemical compound C(CCC)C1=C(C(=C(C(=N1)O)C(=O)N1CCN(CC1)CC1=NC=CC=C1)O)C1=C(C=CC=C1OC)OC WEUGCKQKZYZKNZ-UHFFFAOYSA-N 0.000 claims 2
- QXEDHBPTCFNKCI-UHFFFAOYSA-N 6-butyl-5-(2,6-dimethoxyphenyl)-4-hydroxy-3-[4-[(2-methylphenyl)methyl]piperidine-1-carbonyl]-1H-pyridin-2-one Chemical compound C(CCC)C1=C(C(=C(C(=N1)O)C(=O)N1CCC(CC1)CC1=C(C=CC=C1)C)O)C1=C(C=CC=C1OC)OC QXEDHBPTCFNKCI-UHFFFAOYSA-N 0.000 claims 2
- XNAHSRPAEBCQHM-UHFFFAOYSA-N 6-butyl-5-(2,6-dimethoxyphenyl)-4-hydroxy-3-[4-[3-(trifluoromethyl)pyridin-2-yl]piperazine-1-carbonyl]-1H-pyridin-2-one Chemical compound C(CCC)C1=C(C(=C(C(=N1)O)C(=O)N1CCN(CC1)C1=NC=CC=C1C(F)(F)F)O)C1=C(C=CC=C1OC)OC XNAHSRPAEBCQHM-UHFFFAOYSA-N 0.000 claims 2
- XAENNNIGURSVEU-UHFFFAOYSA-N 6-butyl-5-(2,6-dimethoxyphenyl)-4-hydroxy-3-[4-[4-(2-methoxyethoxy)phenyl]piperazine-1-carbonyl]-1H-pyridin-2-one Chemical compound C(CCC)C1=C(C(=C(C(=N1)O)C(=O)N1CCN(CC1)C1=CC=C(C=C1)OCCOC)O)C1=C(C=CC=C1OC)OC XAENNNIGURSVEU-UHFFFAOYSA-N 0.000 claims 2
- XMKJTASDRFSEAG-UHFFFAOYSA-N 6-butyl-5-(2,6-dimethoxyphenyl)-4-hydroxy-3-[4-[4-(trifluoromethyl)pyrimidin-2-yl]piperazine-1-carbonyl]-1H-pyridin-2-one Chemical compound C(CCC)C1=C(C(=C(C(=N1)O)C(=O)N1CCN(CC1)C1=NC=CC(=N1)C(F)(F)F)O)C1=C(C=CC=C1OC)OC XMKJTASDRFSEAG-UHFFFAOYSA-N 0.000 claims 2
- JHFWPXHWYILCHT-UHFFFAOYSA-N 6-butyl-5-(2,6-dimethoxyphenyl)-4-hydroxy-3-[4-[[3-(trifluoromethyl)phenyl]methyl]piperazine-1-carbonyl]-1H-pyridin-2-one Chemical compound C(CCC)C1=C(C(=C(C(=N1)O)C(=O)N1CCN(CC1)CC1=CC(=CC=C1)C(F)(F)F)O)C1=C(C=CC=C1OC)OC JHFWPXHWYILCHT-UHFFFAOYSA-N 0.000 claims 2
- SLJMIFFMIFPMMT-UHFFFAOYSA-N 6-butyl-5-(2,6-dimethoxyphenyl)-N-[2-(2-fluorophenyl)ethyl]-4-hydroxy-2-oxo-N-propyl-1H-pyridine-3-carboxamide Chemical compound C(CCC)C1=C(C(=C(C(=N1)O)C(=O)N(CCC)CCC1=C(C=CC=C1)F)O)C1=C(C=CC=C1OC)OC SLJMIFFMIFPMMT-UHFFFAOYSA-N 0.000 claims 2
- BQIZDKBOPHTRFY-UHFFFAOYSA-N 6-butyl-5-(3-ethylphenyl)-4-hydroxy-3-[5-[(2-methyl-1,3-thiazol-4-yl)methyl]-1,3,4-oxadiazol-2-yl]-1H-pyridin-2-one Chemical compound C(CCC)C1=C(C(=C(C(N1)=O)C=1OC(=NN=1)CC=1N=C(SC=1)C)O)C1=CC(=CC=C1)CC BQIZDKBOPHTRFY-UHFFFAOYSA-N 0.000 claims 2
- QIGKOQAOJOZBKU-SFHVURJKSA-N 6-butyl-5-(3-fluoro-2,6-dimethoxyphenyl)-4-hydroxy-3-[(3R)-3-phenylpyrrolidine-1-carbonyl]-1H-pyridin-2-one Chemical compound C(CCC)C1=C(C(=C(C(=N1)O)C(=O)N1C[C@H](CC1)C1=CC=CC=C1)O)C1=C(C(=CC=C1OC)F)OC QIGKOQAOJOZBKU-SFHVURJKSA-N 0.000 claims 2
- HQNPYEHFAWFXRM-UHFFFAOYSA-N 6-butyl-N-[2-(4-chlorophenyl)ethyl]-5-(2,6-dimethoxyphenyl)-4-hydroxy-N-methyl-2-oxo-1H-pyridine-3-carboxamide Chemical compound C(CCC)C1=C(C(=C(C(=N1)O)C(=O)N(C)CCC1=CC=C(C=C1)Cl)O)C1=C(C=CC=C1OC)OC HQNPYEHFAWFXRM-UHFFFAOYSA-N 0.000 claims 2
- BPQHKPVDBBZUDZ-UHFFFAOYSA-N 6-butyl-N-[2-[(5-chloro-3-fluoropyridin-2-yl)amino]ethyl]-5-(2,6-dimethoxyphenyl)-4-hydroxy-N-methyl-2-oxo-1H-pyridine-3-carboxamide Chemical compound C(CCC)C1=C(C(=C(C(=N1)O)C(=O)N(C)CCNC1=NC=C(C=C1F)Cl)O)C1=C(C=CC=C1OC)OC BPQHKPVDBBZUDZ-UHFFFAOYSA-N 0.000 claims 2
- JDCLSEMPWVJGEQ-UHFFFAOYSA-N 6-cyclopentyl-5-(2,6-dimethoxyphenyl)-3-[3-(3-fluorophenyl)pyrrolidine-1-carbonyl]-4-hydroxy-1H-pyridin-2-one Chemical compound C1(CCCC1)C1=C(C(=C(C(=N1)O)C(=O)N1CC(CC1)C1=CC(=CC=C1)F)O)C1=C(C=CC=C1OC)OC JDCLSEMPWVJGEQ-UHFFFAOYSA-N 0.000 claims 2
- 208000024172 Cardiovascular disease Diseases 0.000 claims 2
- 206010049694 Left Ventricular Dysfunction Diseases 0.000 claims 2
- UWWMFNMBWWRCKQ-UHFFFAOYSA-N N-(2-benzamidoethyl)-6-butyl-5-(2,6-dimethoxyphenyl)-4-hydroxy-N-methyl-2-oxo-1H-pyridine-3-carboxamide Chemical compound CCCCC1=C(C(O)=C(C(=O)N(C)CCNC(=O)C2=CC=CC=C2)C(O)=N1)C1=C(OC)C=CC=C1OC UWWMFNMBWWRCKQ-UHFFFAOYSA-N 0.000 claims 2
- SNHWZOWXLJFEGD-UHFFFAOYSA-N N-[1-[6-butyl-5-(2,6-dimethoxyphenyl)-4-hydroxy-2-oxo-1H-pyridine-3-carbonyl]azetidin-3-yl]-2,3-difluorobenzenesulfonamide Chemical compound CCCCC1=C(C(O)=C(C(=O)N2CC(C2)NS(=O)(=O)C2=C(F)C(F)=CC=C2)C(O)=N1)C1=C(OC)C=CC=C1OC SNHWZOWXLJFEGD-UHFFFAOYSA-N 0.000 claims 2
- MVBNINGALJOTCH-UHFFFAOYSA-N N-[1-[6-butyl-5-(2,6-dimethoxyphenyl)-4-hydroxy-2-oxo-1H-pyridine-3-carbonyl]azetidin-3-yl]benzamide Chemical compound CCCCC1=C(C(O)=C(C(=O)N2CC(C2)NC(=O)C2=CC=CC=C2)C(O)=N1)C1=C(OC)C=CC=C1OC MVBNINGALJOTCH-UHFFFAOYSA-N 0.000 claims 2
- VBXHAJWRRCOBEF-UHFFFAOYSA-N N-benzyl-6-butyl-5-(2,6-dimethoxyphenyl)-4-hydroxy-2-oxo-N-propyl-1H-pyridine-3-carboxamide Chemical compound C(C1=CC=CC=C1)N(C(=O)C=1C(=NC(=C(C=1O)C1=C(C=CC=C1OC)OC)CCCC)O)CCC VBXHAJWRRCOBEF-UHFFFAOYSA-N 0.000 claims 2
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical group C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 claims 2
- 239000003795 chemical substances by application Substances 0.000 claims 2
- 125000004122 cyclic group Chemical group 0.000 claims 2
- 125000000753 cycloalkyl group Chemical group 0.000 claims 2
- 125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 claims 2
- 150000002009 diols Chemical class 0.000 claims 2
- 125000000325 methylidene group Chemical group [H]C([H])=* 0.000 claims 2
- 230000002107 myocardial effect Effects 0.000 claims 2
- 208000010125 myocardial infarction Diseases 0.000 claims 2
- INOVPKZAEASFME-UHFFFAOYSA-N n-propan-2-ylbenzamide Chemical compound CC(C)NC(=O)C1=CC=CC=C1 INOVPKZAEASFME-UHFFFAOYSA-N 0.000 claims 2
- 238000007634 remodeling Methods 0.000 claims 2
- 125000004227 1,3-benzoxazol-2-yl group Chemical group [H]C1=C([H])C([H])=C2N=C(*)OC2=C1[H] 0.000 claims 1
- 125000002941 2-furyl group Chemical group O1C([*])=C([H])C([H])=C1[H] 0.000 claims 1
- FFVGBTZRGSIQAL-UHFFFAOYSA-N 5-(2,6-dimethoxyphenyl)-6-(4-fluorophenyl)-3-[3-(2-fluorophenyl)pyrrolidine-1-carbonyl]-4-hydroxy-1H-pyridin-2-one Chemical compound COC1=C(C(=CC=C1)OC)C=1C(=C(C(=NC=1C1=CC=C(C=C1)F)O)C(=O)N1CC(CC1)C1=C(C=CC=C1)F)O FFVGBTZRGSIQAL-UHFFFAOYSA-N 0.000 claims 1
- MHXSGPZETNDQSO-KRWDZBQOSA-N 6-(ethoxymethyl)-5-(4-fluoro-2,6-dimethoxyphenyl)-4-hydroxy-3-[(3R)-3-phenylpyrrolidine-1-carbonyl]-1H-pyridin-2-one Chemical compound C(C)OCC1=C(C(=C(C(=N1)O)C(=O)N1C[C@H](CC1)C1=CC=CC=C1)O)C1=C(C=C(C=C1OC)F)OC MHXSGPZETNDQSO-KRWDZBQOSA-N 0.000 claims 1
- NIGQZZOSLVKRFR-UHFFFAOYSA-N 6-butyl-5-(2,6-dimethoxyphenyl)-3-[4-(6-fluoro-1,2-benzoxazol-3-yl)piperidine-1-carbonyl]-4-hydroxy-1H-pyridin-2-one Chemical compound CCCCC1=C(C(O)=C(C(=O)N2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(O)=N1)C1=C(OC)C=CC=C1OC NIGQZZOSLVKRFR-UHFFFAOYSA-N 0.000 claims 1
- VGCNPNDZOILGJM-UHFFFAOYSA-N 6-butyl-5-(2,6-dimethoxyphenyl)-4-hydroxy-3-(spiro[1H-2-benzofuran-3,4'-piperidine]-1'-carbonyl)-1H-pyridin-2-one Chemical compound CCCCC1=C(C(O)=C(C(=O)N2CCC3(CC2)OCC2=CC=CC=C32)C(O)=N1)C1=C(OC)C=CC=C1OC VGCNPNDZOILGJM-UHFFFAOYSA-N 0.000 claims 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims 1
- 206010007559 Cardiac failure congestive Diseases 0.000 claims 1
- 206010007572 Cardiac hypertrophy Diseases 0.000 claims 1
- 208000006029 Cardiomegaly Diseases 0.000 claims 1
- 208000031229 Cardiomyopathies Diseases 0.000 claims 1
- 208000003037 Diastolic Heart Failure Diseases 0.000 claims 1
- 206010061216 Infarction Diseases 0.000 claims 1
- 208000006011 Stroke Diseases 0.000 claims 1
- 208000008253 Systolic Heart Failure Diseases 0.000 claims 1
- 150000001721 carbon Chemical group 0.000 claims 1
- 238000007675 cardiac surgery Methods 0.000 claims 1
- 208000029078 coronary artery disease Diseases 0.000 claims 1
- 125000000392 cycloalkenyl group Chemical group 0.000 claims 1
- 206010012601 diabetes mellitus Diseases 0.000 claims 1
- 229940079593 drug Drugs 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 125000005745 ethoxymethyl group Chemical group [H]C([H])([H])C([H])([H])OC([H])([H])* 0.000 claims 1
- 208000018578 heart valve disease Diseases 0.000 claims 1
- 230000007574 infarction Effects 0.000 claims 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims 1
- 239000000203 mixture Substances 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- 238000006467 substitution reaction Methods 0.000 claims 1
- 230000002459 sustained effect Effects 0.000 claims 1
- 238000002560 therapeutic procedure Methods 0.000 claims 1
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562241367P | 2015-10-14 | 2015-10-14 | |
| US62/241,367 | 2015-10-14 | ||
| US201562270659P | 2015-12-22 | 2015-12-22 | |
| US62/270,659 | 2015-12-22 | ||
| PCT/US2016/056769 WO2017066402A1 (en) | 2015-10-14 | 2016-10-13 | 2,4-dihydroxy-nicotinamides as apj agonists |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2018530591A JP2018530591A (ja) | 2018-10-18 |
| JP2018530591A5 true JP2018530591A5 (enExample) | 2019-11-21 |
| JP6837482B2 JP6837482B2 (ja) | 2021-03-03 |
Family
ID=57178558
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018519425A Active JP6837482B2 (ja) | 2015-10-14 | 2016-10-13 | Ａｐｊアゴニストとしての２，４−ジヒドロキシ−ニコチンアミド |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US10392347B2 (enExample) |
| EP (1) | EP3362442B1 (enExample) |
| JP (1) | JP6837482B2 (enExample) |
| KR (1) | KR102707502B1 (enExample) |
| CN (1) | CN108368087B (enExample) |
| AU (1) | AU2016340264B2 (enExample) |
| BR (1) | BR112018007395A2 (enExample) |
| CA (1) | CA3001974A1 (enExample) |
| CL (1) | CL2018000953A1 (enExample) |
| CO (1) | CO2018004968A2 (enExample) |
| EA (1) | EA034857B1 (enExample) |
| ES (1) | ES2774945T3 (enExample) |
| IL (1) | IL258577B (enExample) |
| MX (1) | MX376824B (enExample) |
| PE (1) | PE20181197A1 (enExample) |
| SG (1) | SG10201908839QA (enExample) |
| TW (1) | TW201720796A (enExample) |
| UY (1) | UY36949A (enExample) |
| WO (1) | WO2017066402A1 (enExample) |
| ZA (1) | ZA201802451B (enExample) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9573936B2 (en) | 2015-05-20 | 2017-02-21 | Amgen Inc. | Triazole agonists of the APJ receptor |
| SMT201900427T1 (it) | 2015-06-03 | 2019-09-09 | Bristol Myers Squibb Co | Agonisti di apj a base di 4-idrossi-3-(eteroaril)piridin-2-one per l'uso nel trattamento di disturbi cardiovascolari |
| WO2017096130A1 (en) | 2015-12-04 | 2017-06-08 | Bristol-Myers Squibb Company | Apelin receptor agonists and methods of use |
| SG11201804674UA (en) | 2015-12-16 | 2018-06-28 | Bristol Myers Squibb Co | Heteroarylhydroxypyrimidinones as agonists of the apj receptor |
| ES2895124T3 (es) | 2016-03-24 | 2022-02-17 | Bristol Myers Squibb Co | 6-hidroxi-4-oxo-1,4-dihidropirimidin-5-carboxamidas como agonistas de APJ |
| EP3452466B1 (en) | 2016-05-03 | 2020-08-12 | Amgen Inc. | Heterocyclic triazole compounds as agonists of the apj receptor |
| CN109311821B (zh) | 2016-06-14 | 2022-10-14 | 百时美施贵宝公司 | 作为apj激动剂的6-羟基-5-(苯基/杂芳基磺酰基)嘧啶-4(1h)-酮 |
| ES2844184T3 (es) | 2016-06-14 | 2021-07-21 | Bristol Myers Squibb Co | 4-hidroxi-3-sulfonilpiridin-2(1H)-onas como agonistas del receptor de APJ |
| KR102521956B1 (ko) * | 2016-10-14 | 2023-04-14 | 브리스톨-마이어스 스큅 컴퍼니 | 3-술포닐-5-아미노피리딘-2,4-디올 apj 효능제 |
| EP3541810B1 (en) | 2016-11-16 | 2020-12-23 | Amgen Inc. | Triazole phenyl compounds as agonists of the apj receptor |
| US11191762B2 (en) | 2016-11-16 | 2021-12-07 | Amgen Inc. | Alkyl substituted triazole compounds as agonists of the APJ Receptor |
| EP3541803B1 (en) | 2016-11-16 | 2020-12-23 | Amgen Inc. | Triazole pyridyl compounds as agonists of the apj receptor |
| EP3541792B1 (en) | 2016-11-16 | 2020-12-23 | Amgen Inc. | Triazole furan compounds as agonists of the apj receptor |
| EP3541805B1 (en) | 2016-11-16 | 2020-10-14 | Amgen Inc. | Heteroaryl-substituted triazoles as apj receptor agonists |
| EP3541804B1 (en) | 2016-11-16 | 2025-01-22 | Amgen Inc. | Cycloalkyl substituted triazole compounds as agonists of the apj receptor |
| WO2019089335A1 (en) | 2017-11-03 | 2019-05-09 | Amgen Inc. | Fused triazole agonists of the apj receptor |
| EP3788037A1 (en) | 2018-05-01 | 2021-03-10 | Amgen Inc. | Substituted pyrimidinones as agonists of the apj receptor |
| WO2025153720A1 (en) * | 2024-01-19 | 2025-07-24 | Scenic Biotech Bv | Pla2g15 inhibitors |
Family Cites Families (50)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CH602664A5 (en) | 1973-06-14 | 1978-07-31 | Sandoz Ag | 2-Tert. amino-alkylamino-pyrimidine derivs. |
| ZA835878B (en) * | 1982-08-23 | 1985-03-27 | Warner Lambert Co | Cardiotonic agents |
| GB2263639A (en) | 1992-01-28 | 1993-08-04 | Merck & Co Inc | Substituted pyrimidinones as neurotensin antagonists |
| DE4425616A1 (de) * | 1994-07-20 | 1996-01-25 | Basf Ag | Hydroxypyridoncarbonsäureamide, deren Herstellung und Verwendung |
| KR100579765B1 (ko) | 1996-07-01 | 2006-12-28 | 닥터 레디스 레보러터리즈 리미티드 | 신규헤테로고리형화합물의제조방법,이를함유하는약제조성물및당뇨병및이와관련된질병의치료에있어서그의용도 |
| EP1301490A2 (en) | 2000-07-18 | 2003-04-16 | Neurogen Corporation | 5-substituted 2-aryl-4-pyrimidinones |
| TW200300349A (en) | 2001-11-19 | 2003-06-01 | Sankyo Co | A 4-oxoqinoline derivative |
| JP2006508030A (ja) | 2002-05-09 | 2006-03-09 | サイトキネティクス・インコーポレーテッド | ピリミジノン化合物、組成物および方法 |
| EP1509507A4 (en) | 2002-05-23 | 2006-09-13 | Merck & Co Inc | INHIBITORS OF MITOTIC KINESINE |
| JP2004339159A (ja) | 2003-05-16 | 2004-12-02 | Sankyo Co Ltd | ４−オキソキノリン誘導体を含有する医薬組成物 |
| US7790734B2 (en) | 2003-09-08 | 2010-09-07 | Takeda Pharmaceutical Company Limited | Dipeptidyl peptidase inhibitors |
| US20050197327A1 (en) | 2003-11-03 | 2005-09-08 | Gustave Bergnes | Compounds, compositions, and methods |
| US7625912B2 (en) | 2003-12-19 | 2009-12-01 | Merck & Co. Inc | Mitotic kinesin inhibitors |
| US7732613B2 (en) | 2005-09-14 | 2010-06-08 | Bristol-Myers Squibb Company | Met kinase inhibitors |
| WO2007037543A1 (ja) | 2005-09-29 | 2007-04-05 | Banyu Pharmaceutical Co., Ltd. | ビアリールアミド誘導体 |
| EP1963329B1 (en) | 2005-11-30 | 2013-01-23 | Vertex Pharmaceuticals Incorporated | Inhibitors of c-met and uses thereof |
| US8367845B2 (en) | 2006-04-21 | 2013-02-05 | The Trustees Of Boston University | Ionic viscoelastics and viscoelastic salts |
| JP2007308441A (ja) * | 2006-05-22 | 2007-11-29 | Sumitomo Chemical Co Ltd | 含複素環化合物及びその用途 |
| WO2008052861A2 (de) | 2006-10-10 | 2008-05-08 | Proionic Production Of Ionic Substances Gmbh & Co Keg | Verfahren zur herstellung von 1,3 -hetero-aromatischen carbonaten |
| EP2079707B1 (de) | 2006-10-10 | 2014-12-03 | proionic GmbH & Co KG | Verfahren zur umsetzung von 1,3-hetero-aromatischen 2-carboxylaten mit wasser |
| CL2008000065A1 (es) | 2007-01-12 | 2008-09-22 | Smithkline Beecham Corp | Compuestos derivados de glicina n-sustituida, inhibidores de hif prolil hidroxilasas; su proceso de preparacion; composicion farmaceutica que comprende a dichos compuestos; y su uso en el tratamiento de la anemia. |
| JP2010519204A (ja) | 2007-02-16 | 2010-06-03 | アムジエン・インコーポレーテツド | 窒素含有複素環ケトン類およびそれらのｃ−Ｍｅｔ阻害薬としての使用 |
| WO2009129120A2 (en) | 2008-04-15 | 2009-10-22 | Rfs Pharma, Llc | Nucleoside derivatives for treatment of caliciviridae infections, including norovirus infections |
| US20110253929A1 (en) | 2008-12-22 | 2011-10-20 | Basf Se | Mixtures of hydrophobic and hydrophilic ionic liquids and use thereof in liquid ring compressors |
| US9040538B2 (en) | 2009-05-21 | 2015-05-26 | Universite Laval | Pyrimidines as novel therapeutic agents |
| EP2604260B1 (en) | 2010-08-10 | 2017-05-10 | Shionogi&Co., Ltd. | Novel heterocyclic derivatives and pharmaceutical composition containing same |
| EP2714698B1 (en) | 2011-05-31 | 2016-11-09 | Merck Patent GmbH | Compounds containing hydrido-tricyano-borate anions |
| TW201311709A (zh) | 2011-05-31 | 2013-03-16 | Merck Patent Gmbh | 電解質配方 |
| US20140005181A1 (en) * | 2012-06-21 | 2014-01-02 | Sanford-Burnham Medical Research Institute | Small molecule antagonists of the apelin receptor for the treatment of disease |
| WO2014004676A1 (en) | 2012-06-26 | 2014-01-03 | Ironwood Pharmaceuticals, Inc. | Use of faah inhibitors as neuroprotective agents in the cns |
| DK2897939T3 (en) * | 2012-09-21 | 2017-05-08 | Sanofi Sa | BENZOIMIDAZOLCARBOXYL ACID AMIDE DERIVATIVES FOR THE TREATMENT OF METABOLIC OR CARDIOVASCULAR DISEASES |
| DE102012021452A1 (de) | 2012-10-31 | 2014-04-30 | Merck Patent Gmbh | Salze mit Trihydroperfluoralkoxybutansulfonat- oder Trihydroperfluoralkoxypropansulfonat-Anion |
| CN105358531B (zh) | 2013-03-14 | 2017-11-14 | 利兰-斯坦福大学初级学院的董事会 | 线粒体醛脱氢酶‑2调节剂和其使用方法 |
| HUE043705T2 (hu) | 2013-06-27 | 2019-09-30 | Pfizer | Heteroaromás vegyületek és dopamin D1 ligandumként történõ alkalmazásuk |
| WO2014207100A1 (en) | 2013-06-27 | 2014-12-31 | Basf Se | A process for coating paper with cellulose using a solution containing cellulose |
| WO2015079028A1 (de) | 2013-11-29 | 2015-06-04 | Vtu Holding Gmbh | Verrfahren zum aushärten eines klebstoffs mittels mikrowellenbestrahlung |
| WO2015184011A2 (en) | 2014-05-28 | 2015-12-03 | Sanford-Burnham Medical Research Institute | Agonists of the apelin receptor and methods of use thereof |
| JP6767878B2 (ja) * | 2014-06-06 | 2020-10-14 | リサーチ トライアングル インスティテュート | アペリン受容体（ａｐｊ）アゴニストおよびそれらの使用 |
| WO2016074757A1 (de) | 2014-11-11 | 2016-05-19 | Merck Patent Gmbh | Verfahren zur herstellung von mono- und bis(perfluoralkyl)fluorophosphatsalzen und deren säuren |
| DK3287443T3 (da) | 2015-04-24 | 2022-02-07 | Shionogi & Co | 6-leddet heterocyklisk derivat og farmaceutisk sammensætning, som omfatter dette |
| US9573936B2 (en) | 2015-05-20 | 2017-02-21 | Amgen Inc. | Triazole agonists of the APJ receptor |
| SMT201900427T1 (it) | 2015-06-03 | 2019-09-09 | Bristol Myers Squibb Co | Agonisti di apj a base di 4-idrossi-3-(eteroaril)piridin-2-one per l'uso nel trattamento di disturbi cardiovascolari |
| KR101711744B1 (ko) | 2015-07-16 | 2017-03-02 | 경희대학교 산학협력단 | 옥사디아졸 유도체, 이의 제조방법 및 이를 포함하는 전자수송층 |
| US10626096B2 (en) | 2015-11-24 | 2020-04-21 | Sanford Burnham Prebys Medical Discovery Institute | Azole derivatives as apelin receptor agonist |
| WO2017096130A1 (en) | 2015-12-04 | 2017-06-08 | Bristol-Myers Squibb Company | Apelin receptor agonists and methods of use |
| SG11201804674UA (en) | 2015-12-16 | 2018-06-28 | Bristol Myers Squibb Co | Heteroarylhydroxypyrimidinones as agonists of the apj receptor |
| ES2895124T3 (es) | 2016-03-24 | 2022-02-17 | Bristol Myers Squibb Co | 6-hidroxi-4-oxo-1,4-dihidropirimidin-5-carboxamidas como agonistas de APJ |
| ES2844184T3 (es) | 2016-06-14 | 2021-07-21 | Bristol Myers Squibb Co | 4-hidroxi-3-sulfonilpiridin-2(1H)-onas como agonistas del receptor de APJ |
| CN109311821B (zh) | 2016-06-14 | 2022-10-14 | 百时美施贵宝公司 | 作为apj激动剂的6-羟基-5-(苯基/杂芳基磺酰基)嘧啶-4(1h)-酮 |
| KR102521956B1 (ko) | 2016-10-14 | 2023-04-14 | 브리스톨-마이어스 스큅 컴퍼니 | 3-술포닐-5-아미노피리딘-2,4-디올 apj 효능제 |
-
2016
- 2016-10-13 US US15/767,364 patent/US10392347B2/en active Active
- 2016-10-13 PE PE2018000536A patent/PE20181197A1/es unknown
- 2016-10-13 MX MX2018004344A patent/MX376824B/es active IP Right Grant
- 2016-10-13 TW TW105133123A patent/TW201720796A/zh unknown
- 2016-10-13 BR BR112018007395A patent/BR112018007395A2/pt not_active IP Right Cessation
- 2016-10-13 EP EP16784732.6A patent/EP3362442B1/en active Active
- 2016-10-13 WO PCT/US2016/056769 patent/WO2017066402A1/en not_active Ceased
- 2016-10-13 AU AU2016340264A patent/AU2016340264B2/en not_active Ceased
- 2016-10-13 CN CN201680072835.5A patent/CN108368087B/zh active Active
- 2016-10-13 EA EA201890858A patent/EA034857B1/ru not_active IP Right Cessation
- 2016-10-13 ES ES16784732T patent/ES2774945T3/es active Active
- 2016-10-13 JP JP2018519425A patent/JP6837482B2/ja active Active
- 2016-10-13 UY UY0001036949A patent/UY36949A/es unknown
- 2016-10-13 KR KR1020187013119A patent/KR102707502B1/ko active Active
- 2016-10-13 CA CA3001974A patent/CA3001974A1/en not_active Abandoned
- 2016-10-13 SG SG10201908839Q patent/SG10201908839QA/en unknown
-
2018
- 2018-04-09 IL IL258577A patent/IL258577B/en active IP Right Grant
- 2018-04-13 CL CL2018000953A patent/CL2018000953A1/es unknown
- 2018-04-13 ZA ZA2018/02451A patent/ZA201802451B/en unknown
- 2018-05-10 CO CONC2018/0004968A patent/CO2018004968A2/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2018530591A5 (enExample) | ||
| IL258577A (en) | 2,4-dihydroxy-nicotinamides as apj agonists | |
| RU2485114C2 (ru) | Карбоксамидные соединения и их применение в качестве ингибиторов кальпаинов | |
| JP2018535999A5 (enExample) | ||
| JP2018118992A5 (enExample) | ||
| JP2019509319A5 (enExample) | ||
| JP2020515575A5 (enExample) | ||
| JP2019537571A5 (enExample) | ||
| JP2017500364A5 (enExample) | ||
| RU2009121564A (ru) | Азаадамантановые производные и способы применения | |
| JP2011503166A5 (enExample) | ||
| JP2013545744A5 (enExample) | ||
| RU2017124425A (ru) | Производные 2,4-диоксо-хиназолин-6-сульфонамида в качестве ингибиторов parg | |
| JP2018524343A5 (enExample) | ||
| JP2019518036A5 (enExample) | ||
| RU2019132212A (ru) | Селективные ингибиторы hdac6 | |
| RU2008141761A (ru) | ИНГИБИТОРЫ с-МЕТ ПРОТЕИНКИНАЗЫ | |
| RU2008126398A (ru) | Производные гетероарилзамещенного пиперидина в качестве ингибиторов печеночной карнитин пальмитоилтрансферазы (l-cpti) | |
| JP2015528022A5 (enExample) | ||
| JP2014062093A5 (enExample) | ||
| JP2016519096A5 (enExample) | ||
| RU2017125520A (ru) | Соединения, ингибирующие parg | |
| RU2014139601A (ru) | Ингибиторы серин/треониновых киназ | |
| RU2012116207A (ru) | Производные индола в качестве модуляторов crac | |
| JP2014510708A5 (enExample) |